Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(3.05)
# 462
Out of 5,240 analysts
21
Total ratings
80.00%
Success rate
42.01%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Bionano Genomics | Downgrades: Neutral | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
Legacy Education | Initiates Coverage On: Buy | 9 | 7.81 | 4.99% | 1 | Oct 22, 2024 | |
Sonoma Pharmaceutica... | Initiates Coverage On: Buy | 65 | 2.65 | 2352.83% | 1 | Sep 5, 2023 | |
Healthcare Capital | Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Jan 24, 2022 | |
DraftKings | Initiates Coverage On: Overweight | 52 | 41.16 | 26.34% | 1 | Jul 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 130 | 111.97 | 16.1% | 1 | Jul 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 130 | 183.22 | -29.05% | 3 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 72 78 | n/a | n/a | 5 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 6 4 | n/a | n/a | 2 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 3 | Jan 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 60 | n/a | n/a | 1 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 5 | n/a | n/a | 1 | Dec 18, 2019 |